Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor.

Mizukami A, Thomé CH, Ferreira GA, Lanfredi GP, Covas DT, Pitteri SJ, Swiech K, Faça VM.

Front Bioeng Biotechnol. 2019 Jun 26;7:154. doi: 10.3389/fbioe.2019.00154. eCollection 2019.

PMID:
31297369
Free PMC Article
2.

High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation.

de Souza Lima IM, Schiavinato JLDS, Paulino Leite SB, Sastre D, Bezerra HLO, Sangiorgi B, Corveloni AC, Thomé CH, Faça VM, Covas DT, Zago MA, Giacca M, Mano M, Panepucci RA.

Stem Cell Res Ther. 2019 Jul 8;10(1):202. doi: 10.1186/s13287-019-1318-6.

3.

The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma.

Ferreira GA, Thomé CH, Simão AMS, Scheucher PS, Silva CLA, Chahud F, Ciancaglini P, Leopoldino AM, Rego EM, Faça VM, Dos Santos GA.

Leuk Lymphoma. 2019 May 7:1-11. doi: 10.1080/10428194.2019.1607326. [Epub ahead of print]

PMID:
31060403
4.

The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers.

Carvalho VP, Grassi ML, Palma CS, Carrara HHA, Faça VM, Candido Dos Reis FJ, Poersch A.

Transl Res. 2019 Apr;206:71-90. doi: 10.1016/j.trsl.2018.11.001. Epub 2018 Nov 20. Review.

PMID:
30529050
5.

The highly efficient powerhouse in the Wistar audiogenic rat, an epileptic rat strain.

Dechandt CRP, Vicentini TM, Lanfredi GP, Silva-Jr RMP, Espreafico EM, de Oliveira JAC, Faça VM, Garcia-Cairasco N, Alberici LC.

Am J Physiol Regul Integr Comp Physiol. 2019 Mar 1;316(3):R243-R254. doi: 10.1152/ajpregu.00254.2018. Epub 2018 Dec 5.

PMID:
30517024
6.

Insights on a putative aminoacyl-tRNA-protein transferase of Leishmania major.

Sharma R, Terrão MC, Castro FF, Breitling R, Faça V, Oliveira EB, Cruz AK.

PLoS One. 2018 Sep 12;13(9):e0203369. doi: 10.1371/journal.pone.0203369. eCollection 2018.

7.

Quantification of Coagulation Factor VIII by Selective Reaction Monitoring.

do Nascimento Filho EG, Lanfredi GP, Abreu-Neto MS, Covas DT, Faça VM.

Methods Mol Biol. 2018;1674:275-282. doi: 10.1007/978-1-4939-7312-5_22.

PMID:
28921445
8.

Selective Reaction Monitoring Mass Spectrometry for Quantitation of Glycolytic Enzymes in Postmortem Brain Samples.

Lanfredi G, Reis-de-Oliveira G, Saia-Cereda VM, Guest PC, Martins-de-Souza D, Faça VM.

Adv Exp Med Biol. 2017;974:205-212. doi: 10.1007/978-3-319-52479-5_16.

PMID:
28353237
9.

Profiling Cell Lines Nuclear Sub-proteome.

Poersch A, Maria AG, Palma CS, Grassi ML, Albuquerque D, Thomé CH, Faça VM.

Methods Mol Biol. 2017;1550:35-46. doi: 10.1007/978-1-4939-6747-6_4.

PMID:
28188521
10.

DIA is not a new mass spectrometry acquisition method.

Martins-de-Souza D, Faça VM, Gozzo FC.

Proteomics. 2017 Apr;17(7). doi: 10.1002/pmic.201700017. Epub 2017 Mar 3.

PMID:
28130891
11.

Selective Reaction Monitoring for Quantitation of Cellular Proteins.

Faça VM.

Methods Mol Biol. 2017;1546:213-221.

PMID:
27896771
12.

Differential Gel Electrophoresis (DIGE) Evaluation of Naphthoimidazoles Mode of Action: A Study in Trypanosoma cruzi Bloodstream Trypomastigotes.

Brunoro GV, Faça VM, Caminha MA, Ferreira AT, Trugilho M, de Moura KC, Perales J, Valente RH, Menna-Barreto RF.

PLoS Negl Trop Dis. 2016 Aug 23;10(8):e0004951. doi: 10.1371/journal.pntd.0004951. eCollection 2016 Aug.

13.

Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.

Grassi ML, Palma CS, Thomé CH, Lanfredi GP, Poersch A, Faça VM.

J Proteomics. 2017 Jan 16;151:2-11. doi: 10.1016/j.jprot.2016.06.009. Epub 2016 Jul 6.

PMID:
27394697
14.

DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.

Sangiorgi B, De Freitas HT, Schiavinato JL, Leão V, Haddad R, Orellana MD, Faça VM, Ferreira GA, Covas DT, Zago MA, Panepucci RA.

Cytotherapy. 2016 Jul;18(7):846-59. doi: 10.1016/j.jcyt.2016.04.004.

PMID:
27260206
15.

Proteomic Analysis of Mesenchymal Stem Cells.

Faça VM, Orellana MD, Greene LJ, Covas DT.

Methods Mol Biol. 2016;1416:509-19. doi: 10.1007/978-1-4939-3584-0_31.

PMID:
27236693
16.

A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.

Poersch A, Grassi ML, Carvalho VP, Lanfredi GP, Palma CS, Greene LJ, de Sousa CB, Carrara HHA, Candido Dos Reis FJ, Faça VM.

J Proteomics. 2016 Aug 11;145:226-236. doi: 10.1016/j.jprot.2016.05.005. Epub 2016 May 21.

PMID:
27222041
17.

Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.

Palma Cde S, Grassi ML, Thomé CH, Ferreira GA, Albuquerque D, Pinto MT, Ferreira Melo FU, Kashima S, Covas DT, Pitteri SJ, Faça VM.

Mol Cell Proteomics. 2016 Mar;15(3):906-17. doi: 10.1074/mcp.M115.052910. Epub 2016 Jan 13.

18.

The secretome analysis by high-throughput proteomics and multiple reaction monitoring (MRM).

Faça VM, Palma CS, Albuquerque D, Canchaya GN, Grassi ML, Epifânio VL, de Oliveira EB.

Methods Mol Biol. 2014;1156:323-35. doi: 10.1007/978-1-4939-0685-7_22.

PMID:
24791999
19.

Comparative metabolism of cellulose, sophorose and glucose in Trichoderma reesei using high-throughput genomic and proteomic analyses.

Dos Santos Castro L, Pedersoli WR, Antoniêto ACC, Steindorff AS, Silva-Rocha R, Martinez-Rossi NM, Rossi A, Brown NA, Goldman GH, Faça VM, Persinoti GF, Silva RN.

Biotechnol Biofuels. 2014 Mar 21;7(1):41. doi: 10.1186/1754-6834-7-41.

20.

Disrupting membrane raft domains by alkylphospholipids.

Gomide AB, Thomé CH, dos Santos GA, Ferreira GA, Faça VM, Rego EM, Greene LJ, Stabeli RG, Ciancaglini P, Itri R.

Biochim Biophys Acta. 2013 May;1828(5):1384-9. doi: 10.1016/j.bbamem.2013.01.017. Epub 2013 Feb 1.

21.

Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity.

Thomé CH, dos Santos GA, Ferreira GA, Scheucher PS, Izumi C, Leopoldino AM, Simão AM, Ciancaglini P, de Oliveira KT, Chin A, Hanash SM, Falcão RP, Rego EM, Greene LJ, Faça VM.

Mol Cell Proteomics. 2012 Dec;11(12):1898-912. doi: 10.1074/mcp.M112.019661. Epub 2012 Sep 22.

22.

A quantitative proteomic and transcriptomic comparison of human mesenchymal stem cells from bone marrow and umbilical cord vein.

Miranda HC, Herai RH, Thomé CH, Gomes GG, Panepucci RA, Orellana MD, Covas DT, Muotri AR, Greene LJ, Faça VM.

Proteomics. 2012 Aug;12(17):2607-17. doi: 10.1002/pmic.201200111. Epub 2012 Aug 7.

PMID:
22778083
23.

Production of human factor VIII-FL in 293T cells using the bicistronic MGMT(P140K)-retroviral vector.

Fontes AM, Melo FU, Greene LJ, Faça VM, Lin Y, Gerson SL, Covas DT.

Genet Mol Res. 2012 Mar 22;11(1):775-89. doi: 10.4238/2012.March.22.8.

24.

SK-HEP cells and lentiviral vector for production of human recombinant factor VIII.

da Rosa NG, Swiech K, Picanço-Castro V, Russo-Carbolante EM, Soares Neto MA, de Castilho-Fernandes A, Faça VM, Fontes AM, Covas DT.

Biotechnol Lett. 2012 Aug;34(8):1435-43. doi: 10.1007/s10529-012-0925-4. Epub 2012 Apr 10.

PMID:
22488441
25.

Human mesenchymal stromal cell proteomics: contribution for identification of new markers and targets for medicine intervention.

Faça VM.

Expert Rev Proteomics. 2012 Apr;9(2):217-30. doi: 10.1586/epr.12.9. Review.

PMID:
22462791
26.

Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition.

Kani K, Faca VM, Hughes LD, Zhang W, Fang Q, Shahbaba B, Luethy R, Erde J, Schmidt J, Pitteri SJ, Zhang Q, Katz JE, Gross ME, Plevritis SK, McIntosh MW, Jain A, Hanash S, Agus DB, Mallick P.

Mol Cancer Ther. 2012 May;11(5):1071-81. doi: 10.1158/1535-7163.MCT-11-0852. Epub 2012 Mar 12.

27.

Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM.

Cancer Res. 2011 Dec 15;71(24):7670-82. doi: 10.1158/0008-5472.CAN-11-0964. Epub 2011 Oct 10.

28.

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, Depinho RA, Kemp CJ, Varmus HE, Hanash SM.

Cancer Cell. 2011 Sep 13;20(3):289-99. doi: 10.1016/j.ccr.2011.08.007.

29.

Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.

Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash S, Agus DB, McIntosh MW, Mallick P.

PLoS One. 2011;6(7):e23090. doi: 10.1371/journal.pone.0023090. Epub 2011 Jul 29.

30.

Mining the plasma proteome for disease applications across seven logs of protein abundance.

Zhang Q, Faca V, Hanash S.

J Proteome Res. 2011 Jan 7;10(1):46-50. doi: 10.1021/pr101052y. Epub 2010 Nov 29. Review.

PMID:
21062094
31.

Interaction of 10-(octyloxy) decyl-2-(trimethylammonium) ethyl phosphate with mimetic membranes and cytotoxic effect on leukemic cells.

dos Santos GA, Thomé CH, Ferreira GA, Yoneda JS, Nobre TM, Daghastanli KR, Scheucher PS, Gimenes-Teixeira HL, Constantino MG, de Oliveira KT, Faça VM, Falcão RP, Greene LJ, Rego EM, Ciancaglini P.

Biochim Biophys Acta. 2010 Sep;1798(9):1714-23. doi: 10.1016/j.bbamem.2010.05.013. Epub 2010 May 19.

32.

Elafin is a biomarker of graft-versus-host disease of the skin.

Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V, Pitteri S, Zhang Q, Chin A, Kitko C, Mineishi S, Yanik G, Peres E, Hanauer D, Wang Y, Reddy P, Hanash S, Ferrara JL.

Sci Transl Med. 2010 Jan 6;2(13):13ra2. doi: 10.1126/scitranslmed.3000406.

33.

Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.

Pitteri SJ, JeBailey L, Faça VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q, Cheng KH, Urban N, Hanash SM, Dinulescu DM.

PLoS One. 2009 Nov 19;4(11):e7916. doi: 10.1371/journal.pone.0007916.

34.

Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.

Garcia J, Faca V, Jarzembowski J, Zhang Q, Park J, Hanash S.

J Proteome Res. 2009 Aug;8(8):3791-6. doi: 10.1021/pr800964v.

PMID:
19505085
35.

Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.

Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J, Rossouw J, Jackson R, Hsia J, Chlebowski R, Manson J, Hanash S.

Genome Med. 2009 Apr 29;1(4):47. doi: 10.1186/gm47.

36.

Proteomic global profiling for cancer biomarker discovery.

Faca V, Wang H, Hanash S.

Methods Mol Biol. 2009;492:309-20. doi: 10.1007/978-1-59745-493-3_19.

PMID:
19241042
37.

Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis.

Hung KE, Faca V, Song K, Sarracino DA, Richard LG, Krastins B, Forrester S, Porter A, Kunin A, Mahmood U, Haab BB, Hanash SM, Kucherlapati R.

Cancer Prev Res (Phila). 2009 Mar;2(3):224-33. doi: 10.1158/1940-6207.CAPR-08-0153. Epub 2009 Feb 24.

38.

Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.

Vaisocherová H, Faca VM, Taylor AD, Hanash S, Jiang S.

Biosens Bioelectron. 2009 Mar 15;24(7):2143-8. doi: 10.1016/j.bios.2008.11.015. Epub 2008 Nov 27.

PMID:
19157844
39.

In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding.

Faça VM, Hanash SM.

Cancer Res. 2009 Feb 1;69(3):728-30. doi: 10.1158/0008-5472.CAN-08-3087. Epub 2009 Jan 20. Review.

40.

Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease.

Fang Q, Strand A, Law W, Faca VM, Fitzgibbon MP, Hamel N, Houle B, Liu X, May DH, Poschmann G, Roy L, Stühler K, Ying W, Zhang J, Zheng Z, Bergeron JJ, Hanash S, He F, Leavitt BR, Meyer HE, Qian X, McIntosh MW.

Mol Cell Proteomics. 2009 Mar;8(3):451-66. doi: 10.1074/mcp.M800231-MCP200. Epub 2008 Nov 4.

41.

Precursor-ion mass re-estimation improves peptide identification on hybrid instruments.

Luethy R, Kessner DE, Katz JE, Maclean B, Grothe R, Kani K, Faça V, Pitteri S, Hanash S, Agus DB, Mallick P.

J Proteome Res. 2008 Sep;7(9):4031-9. doi: 10.1021/pr800307m. Epub 2008 Aug 16.

42.

Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.

Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC, Drescher CW, Schummer M, McIntosh MW, Knudsen BS, Hanash SM.

PLoS One. 2008 Jun 18;3(6):e2425. doi: 10.1371/journal.pone.0002425.

43.

A mouse to human search for plasma proteome changes associated with pancreatic tumor development.

Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ, Pereira-Faca SR, Ireton RC, Katayama H, Glukhova V, Phanstiel D, Brenner DE, Anderson MA, Misek D, Scholler N, Urban ND, Barnett MJ, Edelstein C, Goodman GE, Thornquist MD, McIntosh MW, DePinho RA, Bardeesy N, Hanash SM.

PLoS Med. 2008 Jun 10;5(6):e123. doi: 10.1371/journal.pmed.0050123.

44.

A mouse plasma peptide atlas as a resource for disease proteomics.

Zhang Q, Menon R, Deutsch EW, Pitteri SJ, Faca VM, Wang H, Newcomb LF, Depinho RA, Bardeesy N, Dinulescu D, Hung KE, Kucherlapati R, Jacks T, Politi K, Aebersold R, Omenn GS, States DJ, Hanash SM.

Genome Biol. 2008;9(6):R93. doi: 10.1186/gb-2008-9-6-r93. Epub 2008 Jun 3.

45.

Isoform analysis of LC-MS/MS data from multidimensional fractionation of the serum proteome.

Krasnoselsky AL, Faca VM, Pitteri SJ, Zhang Q, Hanash SM.

J Proteome Res. 2008 Jun;7(6):2546-52. doi: 10.1021/pr7007219. Epub 2008 Apr 18.

PMID:
18419151
46.

Mining the plasma proteome for cancer biomarkers.

Hanash SM, Pitteri SJ, Faca VM.

Nature. 2008 Apr 3;452(7187):571-9. doi: 10.1038/nature06916. Review.

PMID:
18385731
47.

Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.

Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda AE, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G, Fitzgibbon M, McIntosh MW, Kemp CJ, Hanash SM.

J Proteome Res. 2008 Apr;7(4):1481-9. doi: 10.1021/pr7007994. Epub 2008 Feb 27.

PMID:
18311905
48.

Human Proteinpedia enables sharing of human protein data.

Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL, Björling E, Blagoev B, Bose R, Brahmachari SK, Burlingame AS, Bustelo XR, Cagney G, Cantin GT, Cardasis HL, Celis JE, Chaerkady R, Chu F, Cole PA, Costello CE, Cotter RJ, Crockett D, DeLany JP, De Marzo AM, DeSouza LV, Deutsch EW, Dransfield E, Drewes G, Droit A, Dunn MJ, Elenitoba-Johnson K, Ewing RM, Van Eyk J, Faca V, Falkner J, Fang X, Fenselau C, Figeys D, Gagné P, Gelfi C, Gevaert K, Gimble JM, Gnad F, Goel R, Gromov P, Hanash SM, Hancock WS, Harsha HC, Hart G, Hays F, He F, Hebbar P, Helsens K, Hermeking H, Hide W, Hjernø K, Hochstrasser DF, Hofmann O, Horn DM, Hruban RH, Ibarrola N, James P, Jensen ON, Jensen PH, Jung P, Kandasamy K, Kheterpal I, Kikuno RF, Korf U, Körner R, Kuster B, Kwon MS, Lee HJ, Lee YJ, Lefevre M, Lehvaslaiho M, Lescuyer P, Levander F, Lim MS, Löbke C, Loo JA, Mann M, Martens L, Martinez-Heredia J, McComb M, McRedmond J, Mehrle A, Menon R, Miller CA, Mischak H, Mohan SS, Mohmood R, Molina H, Moran MF, Morgan JD, Moritz R, Morzel M, Muddiman DC, Nalli A, Navarro JD, Neubert TA, Ohara O, Oliva R, Omenn GS, Oyama M, Paik YK, Pennington K, Pepperkok R, Periaswamy B, Petricoin EF, Poirier GG, Prasad TS, Purvine SO, Rahiman BA, Ramachandran P, Ramachandra YL, Rice RH, Rick J, Ronnholm RH, Salonen J, Sanchez JC, Sayd T, Seshi B, Shankari K, Sheng SJ, Shetty V, Shivakumar K, Simpson RJ, Sirdeshmukh R, Siu KW, Smith JC, Smith RD, States DJ, Sugano S, Sullivan M, Superti-Furga G, Takatalo M, Thongboonkerd V, Trinidad JC, Uhlen M, Vandekerckhove J, Vasilescu J, Veenstra TD, Vidal-Taboada JM, Vihinen M, Wait R, Wang X, Wiemann S, Wu B, Xu T, Yates JR, Zhong J, Zhou M, Zhu Y, Zurbig P, Pandey A.

Nat Biotechnol. 2008 Feb;26(2):164-7. doi: 10.1038/nbt0208-164. No abstract available.

49.

Innovative proteomic approaches for cancer biomarker discovery.

Faca V, Krasnoselsky A, Hanash S.

Biotechniques. 2007 Sep;43(3):279, 281-3, 285. Review.

50.

In-depth quantitative proteomics for pancreatic cancer biomarker discovery.

Faca V, Hanash S.

Expert Opin Med Diagn. 2007 Sep;1(1):81-9. doi: 10.1517/17530059.1.1.81.

PMID:
23489270

Supplemental Content

Support Center